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Dissection of an antibody-catalyzed reaction 
Jon D. Stewart , Joseph F. Krebs , Gary Siuzdak , Anthony J. Berdis , David B. Smithrud , 
and Stephen J. Benkovic 
ABSTRACT Antibody 43C9 acceler-
ates the hydrolysis of a p-ni1ro8Dilide by a 
factor of 2.5 x 105 over the background 
rate In addition to catalyzlna the hydroly-
sis or a series or aromatic esten. Since this 
represents one of the largest rate acceler-
atioas achieved with an antibody, we have 
undertaken a series of studies aimed at 
uncovering the catalytic mechanism of 
43C9. The immunogen, a pbosphonaml-
date, was designed to mimic the geometric 
and electronk cbaracteristics of the tetra-
hedral Intermediate that forms upon nu-
deophlllc attack by hydroude on the am-
Ide substrate. Further studies, however, 
revealed that the catalytic mechanism Is 
more complex and Involves the fortuitous 
formation of a covalent acyl-antibody In-
termediate as a comequeace of comple-
mentary side chain residues at the anti-
body-bindlng site. Several lines of evl-
den ce indicate that the catalytic 
mechanism Involves two key residues: llls-
L91, wblcb acts as a nudeophile to form 
the acyl-antlbody Intermediate, and Arg-
L96, which stabllbes the anionic tetrahe-
dral moieties. Support for tllJs mechanism 
derives from the results of site-directed 
mutagenesis experiments and solvent deu-
terium Isotope effects as wen as direct 
detedloa of the acyl-antibody by electro-
spray mass spectrometry. Despite its par• 
Ual recapitulation of the coune of action of 
emymic counterparts, the reactivity or 
43C9, like other antibodies, Is apparently 
limited by Its afflnlty for the Inducing 
lmmunogen. To go beyond tllJs level, one 
must Introduce additional catalytic func. 
tlonality. particularly general add-base 
catalysis, through either Improvements In 
transition-state analog design or slte-
spedftc mutagenesis. 
Antibodies are capable of catalyzing a va-
riety of chemical transformations (1-5). 
Antigens have been fabricated that struc-
turally resemble high-energy intermediate 
species anticipated in a chemical reaction, 
which can then be used to induce antibod-
ies whose binding energy should stabilize 
such intermediates or their related transi-
tion states along the reaction pathway. For 
an antibody with a typical 0.1 nM affinity 
for its antigen and 1 mM affinity for its 
substrate (defined as the constant for 
antibody·antigen/ substrate dissociation), 
the difference in the free energy of binding 
is :o::9.6 kcal·mo1-1 (1 cal = 4.184 J), which 
translates to an increase in kinetic turnover 
of == 107 if all of the difference in binding 
energy is realized in catalysis. In practice, 
however, most catalytic antibodies do not 
efficiently convert this binding energy to 
catalysis. Consequently, those such as 
43C9, the subject of this review, which 
exhibitlargerateenhancementsoflOS-106, 
are of particular interest. The investigation 
of their mechanism of action is instructive 
from at least two related points of view: (i) 
what fundamental principles of catalysis 
are responsible for the rate acceleration, 
and (ii) what features of the transition-state 
mimic and its complementary antibody site 
are the primary contributors to catalysis. 
This information can serve as the basis for 
obtaining catalytic antibodies possessing 
high catalytic turnover numbers either 
through improvements in the design of the 
eliciting antigen/hapten or through subse-
quent modifications of the binding site 
through chemical or genetic methods. 
Evidence for NudeopbUlc Catalysis by a 
Catalytic Andbody 
Catalytic antibody 43C9 was selected from 
a panel of 44 antibodies that bound the 
phosphonamidate transition-state mimic 4 
(Scheme I) (6). The intent was to find 
catalytic antibodies capable of accelerating 
the hydrolysis of aromatic amide 1. Amide 
hydrolysis at slightly alkaline pH involves 
a putative zwitterionic tetrahedral spe-
cies-one of several tetrahedral species 
interconverting through proton transfers 
and flanked by tetrahedral transition states 
for their formation and decomposition (7). 
Phosphonate derivatives have acted as 
transition-state inhibitors for various es-
terase enzymes and thus closely mimic the 
stereoelectronic features of the transition 
states for hydrolysis of carboxylic esters 
and amides (8). The antibody 43C9 accel-
erated hydrolysis of 1 by a factor of 2.5 x 
105 over the hydrolysis rate measured in 
the absence of antibody at pH 9.0. By 
applying transition-state theory, the value 
of AAGt is calculated to be - 7  .5 
kcal·mo1-1 (9). The difference between 
binding of 1 and 4 to the antibody is an 
index of the available transition-state bind-
ing energy. The binding constant ofhapten 
at pH 9.0 was obtained by titrating the 
antibody with 4 (monitoring the quenching 
of intrinsic antibody fluorescence); the K d 
value equals 0.8 ± 0.2 nM. The binding 
constant of 1 at pH 9.0 was obtained from 
K m and equals 180 ± 20 µ.M. The ratio of 
Kd/ Km provides a A.AGt equal to - 7 .2 
kcal-mo1-1. The agreement between the 
two measures of transition-state stabiliz.a-
tion achieved by the catalytic anb"body is 
more than satisfactory. One might con-
clude from this superficial analysis that the 
hydrolysis catalyzed by 43C9 proceeds by 
a simple, one-step mechanism. The exper-
imental facts, however, reveal another 
story. 
The anb"body-catalyzed hydrolysis of 
p-nitrophenyl ester 2a and p-nitroanilide I 
has been examined by both pre- and 
steady-state kinetic techniques (10). The 
steady-state Micbaelis-Menten parame-
ters, kc.ti Km and kcat, as a function of pH 
are shown in Fig. 1. The data can be fit 
either to a reaction mechanism involving 
the titration of a group at the antigen-
binding site whose dissociation promotes 
substrate hydrolysis or to one that fea-
tures a change in the rate-limiting step 
around a central antibody-bound interme-
diate species due to changes in pH. For 
the p-nitrophenyl ester, the rate constant 
for p-nitrophenol release (measured inde-
pendently) approximates kcat in the pH-
independent region (pH > 9). Thus, the 
apparent pl(. of 9 found for both sub-
strates in the pH rate profiles cannot be 
due to dissociation of a common acid-
base group involved in binding or cataly-
sis. Further support for this conclusion 
obtains from the absence of pH-depen-
dent binding of I, a competitive inhibitor 
of ester hydrolysis that should be sensitive 
to the ionization state of an active-site 
acid-base group. The 10' difference in kcat 
at pH > 9.0 between the two substrates 
also rules out any mechanism involving a 
shared conformational change step such 
as activation of an antibody·substrate 
complex that is rate-limiting in that region. 
The pH independence of K m values for 
both 1 and 2a required by the similar pH 
behavior of kca, and kat!Km, however, 
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suggests that there is no significant accu-
mulation of the putative intermediate. 
Attempts to detect a steady-state inter-
mediate such as an acyl-antibody at low 
pH (pH 7.0) where its accumulation is 
more favorable by stopped-flow or rapid-
quench methods were unsuccessful (10). 
Single 180 incorporation into the acid 
product 3 observed in the presence of  
H i 180 is consistent with an acyl species 
and definitively rules out a symmetrical 
tetrahedral intermediate (11). However, 
using electrospray mass spectrometry, a 
covalently bound species of  mass weight 
equivalent to an acylated antibody was 
recently observed at pH 5.9, which rep-
resented -10% of the total antibody spe-
cies, thus reinforcing our choice of inter-
pretation. This species was not detected 
in a similar experiment in the presence of 
hapten 4. The data were therefore ana-
lyzed by using the kinetic sequence de-
scribed in Scheme II. 
the data were analyzed identically. Values 
for the estimated rate constants are listed 
in Table 1. 
for the antibody-catalyzed reaction is more 
characteristic of nucleophilic attack and 
expulsion of a charged leaving group by a 
nitrogen nucleophile, such as imidazole 
(13-15). Thus, the substituent effect pro-
vides further support for an acyl interme-
diate and against a one-step general base or 
nucleophilic attack mechanism for hydro-
lysis. The inability of  43C'9 to protonate its 
leaving group is underscored by the dra-
matic 80-fold decrease in kcat estimated for
the p-chloroanilide species. 
The substrate specificity of  43C'9 was 
further extended to include a series of  
p-substituted phenyl esters 2b-e (12). In-
terestingly, little or no reactivity was ob-
served with the C01TCsponding m-nitro-
phenyl ester or anilide or the p-chloro-
substituted anilide, despite the fact that 
the m-nitro compounds are bound as well 
as their respective p-nitro derivatives. 
This suggests that a precise, stercochem-
ical orientation of the substrate is neces-
sary within the active site. Since the pH-
dependent hydrolysis of  esters 2b-e by 
43C'9 exhibits kcat and lea,./ Km pH rate 
profiles similar to the p-nitro derivatives, 
g .. 
u .:rt. 
ii 
.:rt. 
2 
j 1
0 
-1 
6 7 8 9 10 11 
pH 
The pH rate profiles for kcat are thus 
indicative of a change in rate-limiting step 
from hydroxide ion-mediated hydrolysis 
of  a steady-state acyl intermediate at low 
pH to either product release (p-nitrophe-
nyl ester) or acylation in the case of esters 
lb-e and the anilide at high pH values. 
The pH rate profiles for kcat/ Km arise 
from a similar pH-dependent change 
from steps involving deacylation to those 
reflecting acylation. The apparent pK. 
observed in the kcat/ Km versus pH rate 
profiles for the esters shifts from 8.9 
(p-Cl) to 9.5 (p-CH 3) and reflects the 
small change in L 2 consistent with a late 
transition state in the acylation reaction 
and, conversely, attenuation of  the sub-
stituent effect in the reverse deacylation. 
Note that the limitation of rate-limiting 
product release imposed by p-nitrophe-
nol is relieved by changing the p substit-
uent, although the advantage is offset by 
a slower acylation rate. 
The rates of the antibody-catalyzed acy· 
lation (ki) for this series of substrates cor-
relate with u, affording a p value of +2.3. 
In contrast, a similar correlation for the 
hydrolysis rates for the same esters in the 
absence of antibody provides a p value of 
+0.8 (12). For comparison, hydrolysis of
phenyl esters via a general base mecha-
nism or by nucleopbilic attack by hydrox-
ide ion is characterized by p values as low
as 0.5-0.7 (13, 14) to 1.0-1.2 (13, 15, 16), 
respectively. The large p value observed 
1 
0 
ff .:rt. 
ii 
.:rt. 
-2
j -3 
-4 
7 8 9 10 11 
pH 
Collectively from the kinetic and ther-
modynamic binding measurements, a free 
energy reaction coordinate diagram was 
constructed for hydrolysis of  the p-nitro-
substituted ester and anilide (Fig. 2) (10). 
There are several striking features of  the 
two reaction profiles. One is the high 
stability of the antibody Ab·P1·P2 com-
plex, which has a /Ji.G equal to 7-12 
kcal·mol- 1 lower than the respective un-
complexed substrates. This tight product 
complex ultimately limits the rate of ester 
hydrolysis at high pH. The second note-
worthy feature is the increased kinetic 
barrier for the formation of  Ab-I from the 
amide relative to the ester substrate so 
that this step ultimately limits amide turn-
over by the antibody at high pH. This free 
energy profile may provide a glimpse of 
bow nonoptimized enzymes may have 
functioned with their efficiency of turn-
over hampered by the unevenness in the 
/Ji.G barriers for the various ground states 
and their respective transition states. We 
will return to a more direct comparison of  
43C'9 to an esterase enzyme later, but the 
remarlcable finding to emphasize now is 
bow far the mechanism of action of  43C'9 
has departed from the simple hydrolysis 
implicit in the original hapten design. One 
simple rationale is that covalent active site 
chemistry becomes more probable the 
higher the affinity of the antibody for the 
transition-state mimic, provided that nu-
cleophilic side chains are made available 
through a requirement for charge neutral-
ization or hydrogen bonding in hapten 
binding. 
Construction of the 43C9 
Mode1Structure 
Flo. 1. pH rate profiles for 43C9-catalyzed hydrolysis of p-nitropbenyl ester 2a (Left) and Recent mechanistic studies of  43C'9 have 
p-nitroanilide I (Right). made use of  site-directed mutagenesis to 
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Scheme II 
probe the roles of individual residues in-
volved in binding and catalysis. These 
experiments were guided by the previ-
ously discussed kinetic studies as well as 
a computer model of the 43C9 Fv frag-
ment with bound ligands (17). Computer 
modeling of antibody variable (V) regions 
takes advantage of both the modular na-
ture of antibody structures as well as the 
high degree of conservation of tertiary 
structure between antibodies with widely 
divergent binding specificities. The 43C9 
model was constructed in several steps 
using the previously published Antibody 
Structural data base (18, 19). Briefly, se-
quence comparisons were used to select 
the framework regions, then the comple-
mentarity-determining loops were con-
structed, and finally the V L (L, light chain) 
and VH (H, heavy chain) regions were 
paired. The first step was to compare the 
primary sequence of the L and H chains of 
43C9 with those of antibodies whose 
three-dimensional structures are known. 
For 43C9, the L chain most resembled 
that of the anti-phosphorylcholine anti-
body McPC603, while the H chain of 43C9 
was most similar to that of the anti-
lysozyme antibody Dl.3. These data base 
sequences were then modified to match 
those of 43C9. The H3 loop is the most 
difficult to model as a result of its high 
diversity in sequence and length, and the 
likely conformation of the 43C9 H3 loop 
was determined by a series of steps after 
examining both the V LIV H interface and 
the binding of antigen (see below). 
Once constructed, the antibody model 
revealed a T-shaped cleft for the antigen-
binding region. The side chain of Arg-L96 
is located at the vertex of the T, where it 
is situated to form a salt bridge with the 
negatively charged phosphonamidate 
group of the hapten. Such interactions 
have previously been observed in anti-
bodies and other proteins that bind phos-
phorus oxyanions (for example, see refs. 
20 and 21). Once docked in this position, 
the hapten fits snugly into the antigen-
binding pocket. Furthermore, this bind-
ing mode clarifies the position of the H3 
loop, since only a few conformations are 
available that do not involve extensive 
steric clashes with the protein or antigen. 
The amide substrate was docked analo-
gously (Fig. 3) (22). The p-nitrophenyl 
portion of the substrate lies within a cleft 
whose walls are formed by Tyr-L32 and 
the -H3 loop with the side chain of Arg-
HlOOA positioned to form a polar hydro-
gen bond with the nitro group of the 
hapten. The acyl portion lies on top of the 
side chain of Trp-H52 and has extensive 
contacts with the Hl and H2 loops. 
The computer model has provided a 
number of insights into the catalytic 
mechanism of 43C9. The proximity of the 
substrate carbonyl to residues His-L91, 
Arg-L96, and Tyr-H95 suggested that 
these residues play roles in catalysis. 
Specifically, the N8 of His-L91 is located 
... 4_5 A from the carbonyl carbon of the 
substrate. On the other hand, the side 
chain of the other active site histidine 
(His-H35) is >7 A from the substrate 
carbonyl, too far for this imidazole to act 
as a nucleophile. The side chain of His-
H35, moreover, is involved in an exten-
sive hydrogen bonding network at the 
bottom of the antigen-binding pocket, 
suggesting that this residue plays a struc-
tural role in maintaining the conforma-
tion of the binding pocket. The hydroxyl 
of Tyr-H95 appears to hydrogen bond 
with one of the oxygens of the hapten; 
this proximity suggested its involvement 
along with Arg-L96 in stabilizing the tet-
rahedral intermediates or transition 
states. The accuracy of the model will 
ultimately be tested by x-ray crystallog-
raphy, but to date its predictions have 
proven remarkably accurate (see below). 
Appllcatioo of the Proton Inventory 
Technique to Antibody Catalysis 
As probes of enzyme mechanisms, the 
solvent isotope effect and proton inven-
tory have found their greatest use with 
the serine proteases (23). This technique 
was used to further evaluate the pro-
posed catalytic mechanism of 43C9, 
fleshed out in view of the modeled anti-
body-substrate complex (Fig. 3). Proton 
inventories of kcat and kcai/ Km at pL 8 are 
bowed downward for the 43C9-catalyzed 
hydrolysis of p-chlorophenyl ester 2b. At 
this pL value, breakdown of the acyl-
Table 1. Kinetic parameters for p-substituted ester hydrolysis by antibody 43C9 at pH 9.3 
R kca . .  s - 1 Km, µ.M k1, µ.M·s-1 k-1, s - 1 k2, s - 1 k-2, s - 1 ks, s - 1 
N02 =25 53 1.3 25 :!: 4 2:180 c::3600 40 :!: 5 
CH3CO =0.87 ... 3000 No value • 1 . 7  ..::1400 >700
CHO 1.0 :!: 0.1 250 :!: 80 
CJ 1.7 :!: 0.2 720 :!: 220 0.15 89 :!: 6 =2.2 c::1200 ... 900 
CH3 0.15 :!: 0.03 ... 3000 •0.25 ..::1900 >600
k3 (60 µ.M·s- 1) and Jc, (330 :!: 40 s - 1) arc assumed to be constant for all substrates since the 
acyl portion is identical in all substrates. Data are from Gibbs et al. (12). 
antibody intermediate represents the 
rate-limiting step. A bowed downward 
proton inventory can most easily be in-
terpreted in terms of a mechanism involv-
ing the transfer of two or more protons in 
a single rate-limiting transition state 
(24)-in this case, breakdown of the tet-
rahedral intermediate by hydroxide ion 
attack on the putative acyl-imidazole. 
Since the pl(. for the tetrahedral inter-
mediate species is close to that of Arg-
L96 [the pKa for an analogous tetrahedral 
intermediate is ""'12.9 (25)), Arg-L96 ei-
ther transfers a proton to the negatively 
charged oxygen of the tetrahedral inter-
mediate or is involved in strong hydrogen 
bonding interactions with the oxygen. 
The second proton observed from the 
proton inventory likely arises from a pro-
ton transfer to the imidazole of the His 
nucleophile. At pL 9.5, a solvent isotope 
effect of ""'1.2 on kcat! K m is obtained for 
the 43C9-catalyzed hydrolysis of p-chlo-
rophenyl ester 2b. For all intents and 
purposes, this is most likely not a solvent 
isotope effect on the acylation step of the 
reaction but instead reflects a viscosity 
effect on substrate binding. All of these 
solvent isotope effects are consistent 
with the change in rate-limiting steps 
required by the kinetic sequence of
Scheme m. 
Probing the Active Site of 43C9 
by Mutagenesi.1 
Using the single-chain Fv version of 43C9, 
which retains the kinetic parameters of 
the parent monoclonal antibody (26), a 
series of site-directed mutagenesis studies 
were undertaken. The His-L91 to Gin 
(H-L91-Q) mutant, which retains a degree 
of hydrogen bonding but no nucleophilic 
capability, possessed no detectable cata-
lytic activity when assayed against the 
p-chlorophenyl ester substrate 2b (22). 
This finding reflects at least a 50-fold 
decrease in catalytic activity. On the other 
hand, the affinity of this mutant for ligands 
is essentially unchanged from that of the 
wild type (Table 2). The results of the 
binding assays demonstrated that the lack 
of observed catalysis was not due to large 
changes in antibody structure or to a lack 
of substrate binding. Hapten binding was 
used as a surrogate for substrate binding 
because of the rapid spontaneous hydrc>-
lysis of the ester substrates and the weak 
binding of anilide 1. Measurement of the 
binding affinity for the hydrolysis prod-
ucts, acid 3 and p-nitrophenol, which cor-
respond to each arm of the L-shaped 
hapten, takes advantage of the strong 
binding of these products to localize 
changes in hapten binding to one region of 
the combining site. Collectively, these ob-
servations support a role for His-L91 as 
the nucleophile in catalysis. Moreover, no 
covalent intermediate was detected by 
electrospray mass spectrometry when the 
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H-L9I-Q mutant was incubated withp-ni-
trophenyl ester la. Substitution of Ser or 
Glu for His-L91 gave mutants with no 
appreciable activity, despite their ability 
to bind ligands. Substitution of a Cys 
residue at position L91 apparently inter-
feres with the formation of the V L intra-
chain disulfide bond involving the natu-
rally occurring Cys residues at L23 and 
L88 since no folded protein was recovered 
(J.D.S., V. A. Roberts, E. D. Getzoff, 
and S.J.B., unpublished data). 
Substitution of Arg-L96 with Gin re-
moves the positive charge while retaining 
some hydrogen bonding ability. The 
R-L96-Q mutant is catalytically inactive, 
supporting a role for this residue in catal-
ysis. In addition, the affinity of this mutant 
for the hapten was reduced some 20-fold, 
while the affinity for the other ligands was 
relatively unaffected (17). These results 
support the notion that the side chain of 
Arg-L96 interacts specifically with the 
phosphonamidate, since it is this group 
that distinguishes the hapten from either 
of the products. Substitution of His for 
Arg-L96 gave a mutant (R-L96-H) that 
lacked catalytic activity. Moreover, its 
affinity for all ligands decreased substan-
tially, suggesting some reorganization of 
the antigen-binding pocket to accommo-
date the larger side chain, which is con-
sistent with the tight packing of side 
chains of the amino acids that form the 
floor of the antigen-binding site (M. W. 
Crowder, J.D.S., V. A. Roberts, E. D. 
Getzoff, and S.J.B., unpublished data). 
Substitution of His-H35 with Asn or Phe 
also appears to disrupt the active site 
structure, as evidenced by their decreased 
affinities for the various ligands (22). Fi-
nally, to probe the role of the hydroxyl of 
F10. 3. Model of 43C9 Fv frapient with bound amide substrate. Selected residues that line 
the antigen-binding site are highlighted. The VL segment is on the left and the VH segment is 
on the right. His-L91, the putative nucleophile, lies near the scissile carbonyl of the substrate 
and Arg-L96 is poised to act as an oxyanion hole. The hydroxyl of Tyr-H95 lies near the 
carbonyl oxygen, while the side chain ofTyr-L32 forms one wall of the antigen binding pocket. 
Tyr-H95 in transition-state binding, this 
residue was changed to Phe. The Y-H95-F 
mutant possessed ==50% of the wild-type 
activity, in accord with the pH rate pro-
files obtained for the wild-type 43C9, 
which did not exlubit involvement of a 
dissociable Tyr residue (22). 
Attempts to Improve the Catalytic 
Effldency of 43C9 
We have explored the possibility of intro-
ducing residues to accomplish the proton-
ation of either the leaving group or the 
tetrahedral species in order to lower the 
free energy requirements during passage 
along the reaction coordinate. The prox-
imity of Tyr-L32 to the leaving group 
suggested that substituting this residue 
with one capable of proton transfer might 
accomplish our goal. Replacement ofTyr-
L32 with His or Glu provided no observ-
able increase in hydrolysis of the p-chlo-
rophenyl ester substrate at pH 7-8.5, 
where the acylation step is mainly rate-
limiting (ref. 22; J.D.S., D.B.S., V. A. 
Roberts, E. D. Getzoff, and S.J.B., un-
published data). This indicates that the 
side chain is improperly positioned for 
proton donation or, in the case of the His 
residue, its p.Ka is below pH 7. The latter 
is a strong possibility because of the elec-
tropositive environment of the antigen-
binding site, resulting from Arg residues at 
positions L96 and HIOOA. Similarly, the 
side chain of Tyr-H95 is located near the 
scissile carbonyl and also provides an 
opportunity for proton donation to the 
tetrahedral species. Unfortunately, the 
Y-H95-H mutation decreased substrate 
binding to the extent that only the p-ni-
trophenyl ester was useful as a substrate 
due to solubility limitations. For this sub-
strate at pH 7.45, where deacylation is 
rate-limiting, the keat value of the mutant 
was reduced 4-fold relative to that of the 
wild type (22). 
A carboxylate side chain was placed 
adjacent to the N• of His-L91 by substi-
tuting Glu for Gln-1.89. We anticipated 
that the resulting hydrogen bond would 
help orient the N3 ofHis-L91 for nucleo-
philic attack and might also facilitate pro-
ton transfer. Unfortunately, the Q-L89-E 
mutant displayed only =50% of the wild-
type activity (J.D.S., V. A. Roberts, 
E. D. Getzoff, and S.J.B., unpublished 
data). Collectively, these results under-
score the exacting constraints that must 
be satisfied to improve turnover. 
Our final approach to rationally im-
prove catalysis by 43C9 was to increase 
product release since this step is rate-
limiting for p-nitropbenyl ester hydroly-
sis at high pH values. As noted above, the 
side chain of Arg-HIOOA is positioned to 
form a charged hydrogen bond with the 
nitro group of the hapten. Presuming that 
this hydrogen bond might be at least 
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partially responsible for slow product re-
lease, Arg-HlOOA was replaced with Gin. 
Thermodynamic binding measurements 
indicated that the affinity o f  the 
R-HlOOA-Q mutant for p-nitrophenol had 
been reduced 4.3-fold relative to that of  
the wild type. Furthermore, direct mea-
surements o f  the on and off rates for 
p-nitrophenol binding to this mutant (22 
µ.M-s-1 and 103 s-1, respectively) indi-
cated that the off rate was increased 
2.5-fold relative to the wild type. This 
increased off rate was manifested by a 
kcat value of  100 s-1 for the p-nitrophenyl 
ester substrate at pH 10, 2.5-fold higher 
than that for the wild-type antibody in the 
pH-independent region (D.B.S., V. A. 
Roberts, E. D. Getzoff, and S.J.B., un-
published data). This provides an exam-
ple of a means for relieving product in-
hibition without deleterious effects on 
the overall turnover o f  the antibody. 
Compartaon or the Mechanism or 43C9 
witll Tbo8e ol AnaJoeous F.nzymes 
From the outset, our goal has been to 
produce antibody catalysts whose effi-
ciencies match those of  highly evolved 
enzymes. This invites two questions: (i) 
to what extent have we succeeded in 
producing effective catalysts, and (ii) to 
what extent do catalytic antibodies re-
semble their enzymic counterparts? An-
tibody 43C9 is a potent catalyst for anil-
ide and ester hydrolysis at p H >  9.0, with 
kca1 values within a factor of 25 and 2, 
respectively, of  chymotrypsin at pH 7.0 
(10). By this criterion, then, we have 
succeeded in producing a catalyst with 
remarkable activity. 
Mechanistic studies of  43C9 have 
shown that an antibody whose evolution 
has been directed toward tighter binding 
of a transition-state analog can recapitu-
late a number of characteristics of an 
enzyme whose evolution has been di-
rected by increased catalytic efficiency. 
Covalent catalysis allows a difficult 
chemical transformation to be broken 
into more manageable units and repre-
sents a common theme in enzyme-
catalyzed amide hydrolysis. The use of a 
His residue as the nucleophile, however, 
appears to be unprecedented. On the 
other hand, this participation is reason-
able since His and Tyr (27) are the only 
residues acting in the absence of  general 
acid-base catalysis that might be ex-
pected to reversibly form acyl-antibody 
intermediates. Nature has circumvented 
this problem in enzymes by constructing 
multiresidue networks involving general 
base catalysis; for example, the Cys-His 
ion pair in the case of  subtilisin or the 
catalytic triad of  the serine proteases. 
The use of an oxyanion hole to stabilize 
the tetrahedral transition states and in-
termediates has also been reproduced by 
43C9. In the case of  carboxypeptidase A, 
which also employs an Arg residue in this 
role, this interaction contributes 6-8 
kcal·mo1-1 to transition-state stabiliza-
tion (28). Unfortunately, we were unable 
to measure the contribution in free en-
ergy of  Arg-L96 to transition-state stabi-
lization in the case of  43C9 since the 
catalytic activity of  the R-L96-Q mutant 
was below our detection limits. 
Condading Remarks 
How can the lessons learned from studies 
of 43C9 be applied to creating more ef-
fective antibody catalysts? First, our re-
sults have underlined the importance of 
high affinity for the transition-state ana-
log, provided that the antigen accurately
represents the transition state for a given 
reaction. It is worth noting that no 43C9 
mutant whose Kd for the transition-state 
analog was > 1 nM displayed catalytic 
Table 2. Thermodynamic dissociation constants for ligand binding and steady-state kinetic parameters for 
p-chloropbenyl ester hydrolysis at pH 8.S and 2S"C by wild-type and mutant 43C9 single-chain antibodies 
Kd 
Protein Hapten, nM Acid, µM Phenol, µM 
Wild type S l  I S ±  1 0.6 ± 0.1 
Y-L32-H* 0.67 ± 0.3S 12 ± 3 0.38 ± 0.09 
Y-L32-E* s 2  1S ± 3 4.3 ± 0.4 
Q-L89-E* :s2 16 ± 3 0.64 ± 0.21 
H-L91-Q* :S} 17 ± 3 O.S3 ± 0.16 
H-L91-S* :st 24 ± 4 2.0 ± 0.3 
H-L91-E* 3{i() ± 10 >200 12 ± 1 
H-H3S-N* 16 ± 2 100 ± 10 s.s ± l.S 
H-H3S-F* 13 ± 6 1S ± 2 1.4 ± 0.1 
R-L96,Qf 16 ± 2 31 ± 8 0.96 ± 0.16 
Y-H9S-F* s 2  2S ± 8 0.65 ± 0.22 
Y-H9S-H* s 2  21 ± 6 0.70 ± 0.18 
R-HlOOA-Qt S l  1S ± 3 2.6 ± o.s 
N A ,  no detectable catalytic activity; SA, slight activity; N D ,  not determined. 
*Data are from Stewart et al. (22). 
*J.D.S., V .  A .  Roberts, E .  D. Getzoff, and S.J.B., unpublished data. 
fData are from Roberts et al. (17). 
to.B.S. ,  V.  A.  Roberts, E.  D. Getzoff, and S.J.B., unpublished data. 
Kinetic parameters 
k.:.t, s-1 K-.,µM 
0.46 ± o.os 470 ± l(iO 
0.17 ± 0.01 1300 ± 100 
N A  N A  
0.22 ± 0.02 1700 ± 200 
N A  N A  
S A  S A  
N A  N A  
N A  N A  
N A  N A  
N A  N A  
0.18 ± 0.01 990 ± 90 
N A  N A  
N D  N D  
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activity. This further underscores the im-
portance o f  hapten design, in particular 
the nature o f  the functional group that 
mimics the reactive moiety in the sub-
strate (29, 30). Anionic phosph(or/on)yl 
ligands have been shown to accurately 
mirror the transition states for enzymes 
that cleave amides, and this has been 
quantitatively demonstrated for both 
J3-lactamase (31) and carboxypeptidase A 
(28). A s  we (32) and Jacobs (33) have 
shown, this relationship also holds for 
antibody catalysis, where a direct corre-
lation exists between the affinity o f  an 
antibody for the transition-state analog 
and its catalytic efficiency. A s  a result, 
the most effective antibody catalysts will 
be those with the highest binding affinity 
for hapten. Methods that provide anti-
bodies whose affinities for the transition-
state analog are s l  n M  are therefore 
crucial to isolating efficient catalysts. Re-
cent advances in cloning and screening 
large combinatorial libraries o f  antibody 
genes should prove useful in this search 
(34), especially since they permit ran-
domly mutated antibody genes to be se-
lected for higher binding affinity. This 
approach alone, however, may be insuf-
ficient to incorporate general acid-base 
catalysis into the mechanism (the major 
deficiency o f  the 43C9 mechanism) un-
less these hydrogen bonding interactions 
nisms and using the antibody-catalyzed 17. 
reactions to provide metabolites required 
Roberts, V.  A. ,  Stewart, J .  D., Benk-
ovic, S. J .  & Getzoff', E .  D. (191)4) J. 
Mol. Biol. 235, 1098-1116. for growth holds considerable promise 
(36), although a generic screen using sur- 18· 
face ionization techniques may eventually 
prove feasible (37). 
Getzoff', E .  D.,  Tainer, J . ,  Lerner, R. A .  
& Geysen, H.  M. (1988) Adv. lmmurwl. 
can be made to measurably contribute to 
antigen binding. Rather, it may be nec-
essary to install the required residues 
later by protein engineering techniques 
unless rules are shown to exist that pre-
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